Prof Terry Nolan
Honorary (Redmond Barry Distinguished Professor Emeritus)
Faculty of Medicine, Dentistry and Health Sciences
321 Scholarly works
37 Projects
HIGHLIGHTS
2025
Journal article
Reactogenicity of an Inactivated, Split-Virion Quadrivalent Influenza Vaccine in Infants and Children Aged ≥6 Months to <9 Years
DOI: 10.3390/vaccines131010192025
Journal article
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses
DOI: 10.1097/INF.00000000000047642025
Journal article
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
DOI: 10.1016/S1473-3099(24)00667-42025
Journal article
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study
DOI: 10.1093/cid/ciae6222022
Research contracts (non-grants)
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
2021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines
2020
Research Grant
A Safe, Effective, and Rapidly Tuneable SARS-CoV-2 Vaccine
RECENT SCHOLARLY WORKS
2025
Journal article
596. Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study
DOI: 10.1093/ofid/ofae631.1912024
Journal article
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
DOI: 10.1016/j.omtm.2024.1013802024
Journal article
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results from a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults
DOI: 10.1093/ofid/ofae6382024
Journal article
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
DOI: 10.1016/j.vaccine.2024.1262512024
Journal article
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
DOI: 10.1093/ofid/ofae4532024
Journal article
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts
DOI: 10.3390/vaccines12070773
RECENT PROJECTS
2019
Research contracts (non-grants)
Victorian Public Health Medicine Training Scheme (VPHMTS)
2021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines